We provide CLIA/CAP next-generation sequencing (NGS) services and testing solutions to help develop and deliver personalized and precision diagnostics.
Our breakthrough NGS technology, diagnostic development expertise and collaborative culture makes us ideal partners for life science companies developing new, targeted therapies that require a companion diagnostic.
We have a global footprint of external partner NGS services that are cutting-edge, CLIA-certified and CAP-accredited.